Amplified Sciences, LLC

West Lafayette, IN · Founded 2016 · Medtech · Private

Diagnostic tests for early disease detection and risk stratification

Claim this profile

Follows are private to you and power your alerts

Updated · amplifiedsciences.com

Sector
Medtech
Headquarters
West Lafayette, IN
Founded
2016
Latest Form D
$550K, Aug 2025
Total capital
$5.4M
Federal grants
$1.1M
4 awards · 2023–2024
Rank in peer group#22 of 95
Private capital raised
$4.3M
3 Form D · last Aug 2025
14 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $5.4M$400K$400K$275K$55K1st Form D$1.1M2nd Form D$2.6M
202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $5.4M$400K$400K$275K$55K1st Form D$1.1M2nd Form D$2.6M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$550K
  • Private capital raisedForm D · SEC · 2nd filing$2.6M
  • Federal grantHealth and Human S · Phase I · Translating a Novel Assay for Risk Stratification of Potentially Malignant Pancreatic Cystic Lesions$55K
  • Federal grantNSF · Phase I · SBIR Phase I: Development of a SERS-based diagnostic platform for multiplexing ubiquitous inflammatory markers in cancer.$275K
  • Federal grantHealth and Human S · Phase I · Translational Assays for Inflammatory Biomarkers for the Risk Stratification of Pancreatic Cystic Lesions$400K
  • Federal grantHealth and Human S · Phase I · Translational Assays for Inflammatory Biomarkers for the Risk Stratification of Pancreatic Cystic Lesions$400K
  • Private capital raisedForm D · SEC · 1st filing$1.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 95 peers

Line = median

Medtech · Instrument

  • Federal grants#22 · top 23%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Andrew Jo CothrelDirectorNamed in SEC Form D filings
  • Diana CaldwellExecutive Officer, DirectorNamed in SEC Form D filings
  • Robert Jo SaundersDirectorNamed in SEC Form D filings
  • Vincent J DavissonDirectorNamed in SEC Form D filings
  • Wade Jo LangeDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .